Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
EryPed, E.E.S.,
Synonyms :
erythromycin ethylsuccinate
Class :
Macrolides
Brand Name :
EryPed, E.E.S.,
Synonyms :
erythromycin ethylsuccinate
Class :
Macrolides
Dosing Form & StrengthsÂ
TabletÂ
400mgÂ
SuspensionÂ
200mg/5mLÂ
400mg/5mLÂ
Group A Streptococcal (GAS) InfectionsÂ
400
mg
Orally 
divided in to 2 times a day
10
days
indicated for Primary syphilis:
48-64 g orally divided doses 10-15 days
800
mg
Orally 
every 8 hrs
7
days
400
mg
orally
4 times a day
10 - 14
days
40 - 50
mg/kg
Orally 
in divided doses
5 - 14
days
Dosing Form & StrengthsÂ
TabletÂ
400mgÂ
SuspensionÂ
200mg/5mLÂ
400mg/5mLÂ
40 - 50
mg/kg
Orally 
every day in divided dose
the maximum dose per day is 4 grams
the duration of therapy is 5-14 days
500
mg
orally/IV
every 6 hrs + rifampin
The duration of therapy is 3 months
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect
measles mumps and rubella vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
It may enhance the effect when combined with grapefruit by CYP3A4 metabolism
It may enhance the effect when combined with miconazole vaginal by affecting CYP3A4 metabolism
nafcillin will decrease the effect of action of erythromycin ethylsuccinate by affecting enzyme CYP3A4 metabolism.
QTc interval is increased both by lenvatinib and erythromycin ethylsuccinate
erythromycin ethyl succinate increases the effect of lapatinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
synthetic conjugated estrogens, bÂ
the activity of synthetic conjugated estrogens B is increased by erythromycin ethylsuccinate
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the levels of serum concentration of cardiac glycosides
may increase the levels of serum concentration of cardiac glycosides
may increase the levels of serum concentration of cardiac glycosides
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
when both drugs combine erythromycin base will increase the effect of ifosfamide by affecting the enzyme CYP3A4 metabolism.
the effect of erythromycin ethylsuccinate is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
may reduce the therapeutic effect of typhoid Vaccine
lansoprazole amoxicillin and clarithromycin
when amoxicillin combines with erythromycin ethylsuccinate it decreases the effects of action of drug by antagonism effect
amoxicillin and clavulanate potassium
when amoxicillin combines with erythromycin ethylsuccinate it decreases the effects of action of drug by antagonism effect
omeprazole amoxicillin and clarithromycin
when amoxicillin combines with erythromycin ethylsuccinate, it decreases the effects of the action of a drug by antagonism effect
when amoxicillin combines with erythromycin ethylsuccinate, it decreases the effects of the action of a drug by antagonism effect
they increase the concentration of rilpivirine
Frequency DefinedÂ
1-10% Â
AnaphylaxisÂ
Headache (8%)Â
FeverÂ
Abdominal pain (8%)Â
Dyspepsia (2%)Â
Hypertrophic pyloric stenosisÂ
Diarrhea (7%)Â
Nausea (8%)Â
Rash (3%)Â
Vomiting (3%)Â
Flatulence (2%)Â
Pruritus (1%)Â
Pseudomembranous colitisÂ
Pain (2%)Â
Â
Pregnancy warnings:   
Pregnancy:
US FDA pregnancy category: B
Lactation:
Excreted into human milk is known
Pregnancy Categories:     
Category A:Â well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B:Â there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women. Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits. Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women. Â
Category N:Â There is no data available for the drug under this category
Generic Name: erythromycin ethylsuccinate
Why do we use erythromycin ethylsuccinate?Â
erythromycin ethylsuccinateis is an Macrolides used to treat a variety of bacterial infections.